Saccharomyces boulardii Inhibits Inflammatory Bowel Disease by Trapping T Cells in Mesenteric Lymph Nodes
Open Access
- 1 December 2006
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 131 (6), 1812-1825
- https://doi.org/10.1053/j.gastro.2006.10.001
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- Sphingosine 1-phosphate and its receptors: an autocrine and paracrine networkNature Reviews Immunology, 2005
- Permeability modulation of human intestinal Caco-2 cell monolayers by interferonsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2005
- Guidelines for the management of inflammatory bowel disease in adultsGut, 2004
- The immunological and genetic basis of inflammatory bowel diseaseNature Reviews Immunology, 2003
- Crohn's diseaseThe Lancet, 2002
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Activation of nuclear factor kappa B in inflammatory bowel diseaseGut, 1998
- Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic miceJournal of Applied Bacteriology, 1996
- Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cellsImmunity, 1994
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994